MX158088A - Procedimiento para preparar una composicion de liberacion controlada a base de un complejo de coordinacion molecular - Google Patents

Procedimiento para preparar una composicion de liberacion controlada a base de un complejo de coordinacion molecular

Info

Publication number
MX158088A
MX158088A MX185453A MX18545381A MX158088A MX 158088 A MX158088 A MX 158088A MX 185453 A MX185453 A MX 185453A MX 18545381 A MX18545381 A MX 18545381A MX 158088 A MX158088 A MX 158088A
Authority
MX
Mexico
Prior art keywords
preparing
procedure
controlled release
composition based
release composition
Prior art date
Application number
MX185453A
Other languages
English (en)
Inventor
Stewart Thomas Leslie
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of MX158088A publication Critical patent/MX158088A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00Preparation of cellulose ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/05Alcohols; Metal alcoholates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
MX185453A 1979-12-19 1981-01-05 Procedimiento para preparar una composicion de liberacion controlada a base de un complejo de coordinacion molecular MX158088A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE2480/79A IE49324B1 (en) 1979-12-19 1979-12-19 Controlled release compositions
IE248179 1979-12-19

Publications (1)

Publication Number Publication Date
MX158088A true MX158088A (es) 1989-01-06

Family

ID=26319271

Family Applications (1)

Application Number Title Priority Date Filing Date
MX185453A MX158088A (es) 1979-12-19 1981-01-05 Procedimiento para preparar una composicion de liberacion controlada a base de un complejo de coordinacion molecular

Country Status (27)

Country Link
US (1) US4366310A (es)
EP (1) EP0032004B1 (es)
JP (1) JPS5698201A (es)
AU (1) AU541246B2 (es)
BE (1) BE886711A (es)
CA (1) CA1168230A (es)
CS (1) CS228142B2 (es)
DE (1) DE3048028A1 (es)
DK (1) DK170347B1 (es)
EG (1) EG14984A (es)
ES (1) ES497906A0 (es)
FI (1) FI66623C (es)
FR (1) FR2474507B1 (es)
GB (1) GB2067569B (es)
GR (1) GR72265B (es)
HU (1) HU188085B (es)
IE (1) IE49324B1 (es)
IL (1) IL61677A (es)
MX (1) MX158088A (es)
NL (1) NL187401C (es)
NO (1) NO152846C (es)
NZ (1) NZ195793A (es)
PL (1) PL133079B1 (es)
PT (1) PT72214B (es)
SU (1) SU1178326A3 (es)
YU (1) YU40957B (es)
ZA (1) ZA807716B (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1211266A (en) * 1982-11-12 1986-09-16 Alfred E. Lauchenauer Shaped semi-solid articles
DE3306621A1 (de) * 1983-02-25 1984-08-30 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von celluloseethern mit einem dimethoxyethan enthaltenden dispergierhilfsmittel
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
DE3750145T2 (de) * 1986-06-10 1994-11-03 Euro Celtique Sa Zusammensetzung mit kontrollierter Freisetzung von Dihydrocodein.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US5079005A (en) * 1988-06-17 1992-01-07 Gupta Kashmiri L Time release protein
US5055300A (en) * 1988-06-17 1991-10-08 Basic Bio Systems, Inc. Time release protein
US5023080A (en) * 1988-06-17 1991-06-11 Basic Bio Systems, Inc. Time release protein
US5476668A (en) * 1990-08-24 1995-12-19 Shin-Etsu Chemical Co., Ltd. Base for film-coating pharmaceuticals and method for preparing same
IL109460A (en) 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
AU8532798A (en) * 1997-06-13 1998-12-30 Roland Bodmeier Compounds which delay the release of active substances
US6277384B1 (en) 1997-12-22 2001-08-21 Euro-Celtique S.A. Opioid agonist/antagonist combinations
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
PT1255547E (pt) 2000-02-08 2008-11-24 Euro Celtique Sa Composições de libertação controlada contendo agonistas e antagonistas opióides
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
PT1416842E (pt) 2001-07-18 2009-03-31 Euro Celtique Sa Composições farmacêuticas de oxicodona e naloxona
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
PL367427A1 (en) 2001-08-06 2005-02-21 Euro-Celtique S.A. Opioid agonist formulations with releasable and sequestered antagonist
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
WO2003013433A2 (en) 2001-08-06 2003-02-20 Euro-Celtique S.A. Sequestered antagonist formulations
MXPA04009713A (es) 2002-04-05 2005-01-11 Euro Celtique Sa Preparacion farmaceutica que contiene oxicodona y naloxona.
DK1551372T3 (en) 2002-09-20 2018-07-23 Alpharma Pharmaceuticals Llc SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
MY135852A (en) 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
SI1765292T1 (en) 2004-06-12 2018-04-30 Collegium Pharmaceutical, Inc. Formulations of medicines to discourage abuse
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
WO2007149438A2 (en) 2006-06-19 2007-12-27 Alpharma, Inc. Pharmaceutical compositions
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
JP2010159364A (ja) * 2009-01-09 2010-07-22 Kyoto Univ セルロースの高温での着色を抑制する方法
MY152279A (en) 2009-03-10 2014-09-15 Euro Celtique Sa Immediate release pharmaceutical compositions comprising oxycodone and naloxone
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
BR112012028656A2 (pt) 2010-05-10 2016-08-09 Euro Celtique Sa combinação de grânulos carregados ativos com ativos adicionais
NZ700732A (en) 2010-05-10 2015-08-28 Euro Celtique Sa Pharmaceutical compositions comprising hydromorphone and naloxone
AU2011252040C1 (en) * 2010-05-10 2015-04-02 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
EA032906B1 (ru) 2010-12-22 2019-08-30 Пэдью Фарма Л.П. Твердая лекарственная форма с контролируемым высвобождением и способы ее получения и применения
KR101458334B1 (ko) 2010-12-23 2014-11-04 퍼듀 퍼머 엘피 탬퍼 저항성 고체 경구 투여 형태
CN105120846B (zh) 2013-02-05 2019-10-18 普渡制药公司 抗篡改的药物制剂
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
UA116567C2 (uk) 2013-07-23 2018-04-10 Євро-Селтік С.А. Комбінація оксикодону та налоксону для застосування в лікуванні болю у пацієнтів, які страждають від болю та захворювання, що призводить до дисбактеріозу кишечнику та/або підвищує ризик кишкової бактеріальної транслокації
BR112016009749A8 (pt) 2013-11-13 2018-01-30 Euro Celtique Sa hidromorfona e naloxona para tratamento de dor e síndrome de disfunção intestinal opioide
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264766A (en) * 1877-09-19 1981-04-28 Hoffmann-La Roche Inc. Immunological diagnostic reagents
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
US3988482A (en) * 1971-08-27 1976-10-26 Toyo Hakka Kogyo Kabushiki Kaisha Menthol glycoside, process for preparing the same and method for releasing menthol therefrom
US3818107A (en) * 1972-09-28 1974-06-18 Brook D Chewing gum with sustained flavor release compositions
US3899439A (en) * 1973-03-12 1975-08-12 Hercules Inc Method of preparing aqueous dispersions of hydroxypropyl cellulose
DE2644678A1 (de) * 1976-10-02 1978-04-06 Dynamit Nobel Ag Verfahren zur herstellung funktionalisierter cellulosen
JPS54105223A (en) * 1977-12-29 1979-08-18 Yamanouchi Pharmaceut Co Ltd Coating agent for solid medicine
US4259355A (en) * 1979-03-05 1981-03-31 International Flavors & Fragrances Inc. Chewing gum containing flavor composition and flavor composition therefor
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals

Also Published As

Publication number Publication date
SU1178326A3 (ru) 1985-09-07
JPS5698201A (en) 1981-08-07
HU188085B (en) 1986-03-28
JPH0225921B2 (es) 1990-06-06
IE49324B1 (en) 1985-09-18
IL61677A (en) 1984-10-31
CA1168230A (en) 1984-05-29
FI66623C (fi) 1984-11-12
ZA807716B (en) 1981-12-30
ES8303489A1 (es) 1983-02-01
CS228142B2 (en) 1984-05-14
DK170347B1 (da) 1995-08-07
IL61677A0 (en) 1981-01-30
NL187401C (nl) 1991-09-16
EG14984A (en) 1986-06-30
IE792480L (en) 1981-06-19
PT72214B (en) 1981-11-02
PT72214A (en) 1980-08-01
EP0032004B1 (en) 1985-05-15
PL228573A1 (es) 1982-07-19
FR2474507B1 (fr) 1986-12-26
FR2474507A1 (fr) 1981-07-31
HUT34891A (en) 1985-05-28
NZ195793A (en) 1982-09-14
EP0032004A2 (en) 1981-07-15
NO803836L (no) 1981-06-22
ES497906A0 (es) 1983-02-01
NO152846B (no) 1985-08-19
YU40957B (en) 1986-08-31
DK527680A (da) 1981-08-05
FI66623B (fi) 1984-07-31
YU321080A (en) 1983-06-30
AU541246B2 (en) 1985-01-03
DE3048028A1 (de) 1981-09-10
US4366310A (en) 1982-12-28
GB2067569A (en) 1981-07-30
AU6529880A (en) 1981-06-25
NO152846C (no) 1985-11-27
NL187401B (nl) 1991-04-16
GB2067569B (en) 1983-09-01
FI803848L (fi) 1981-06-20
GR72265B (es) 1983-10-10
PL133079B1 (en) 1985-05-31
BE886711A (fr) 1981-06-17
NL8006891A (nl) 1981-07-16
EP0032004A3 (en) 1982-07-14

Similar Documents

Publication Publication Date Title
MX158088A (es) Procedimiento para preparar una composicion de liberacion controlada a base de un complejo de coordinacion molecular
AR227069A1 (es) Procedimiento para preparar una composicion a base de amino-2-trifluormetoxi-6-benzotiazol
MX3620E (es) Procedimiento para preparar 2(4(tetrahidro-2-furoil)-piperazino)-4-amino-6,7-dimetoxiquinazolina
ES491604A0 (es) Un procedimiento para preparar, una composicion fotopolime- rizable.
ES495376A0 (es) Un procedimiento para preparar un compuesto de 1,8-naftiri- dina
ES493061A0 (es) Un procedimiento para preparar un lipopolisacarido
AR214227A1 (es) Un procedimiento para preparar una composicion polimera de propileno
ES490166A0 (es) Un procedimiento para preparar mercaptoacildipeptidos
ES495520A0 (es) Un procedimiento para preparar una d-6-n-propilergolina
AR227284A1 (es) Procedimiento para preparar antraceno-9,10-bis-carbonil-hidrazonas
ES497302A0 (es) Un procedimiento para preparar 9-aminoalquilfluorenos
MX5976E (es) Procedimiento mejorado para preparar una composicion farmaceutica a partir de cefalexina
ES490686A0 (es) Un procedimiento para preparar una resina de fenol-formal- dehido modificada
ES494459A0 (es) Un procedimiento para preparar cetoximinoeteres
ES494530A0 (es) Procedimiento para preparar una composicion de catalizador
ES493798A0 (es) Un procedimiento para preparar 7-alcoxicarbonil-6,8-dime- til-4-hidroximetil-1-ftalazona
DK238280A (da) Fremgangsmaade til fremstilling af 10,11-dihydro5h-dibenzo(a,d)cyclohepten-5,10-iminer
ES496859A0 (es) Un procedimiento para preparar derivados de halofenil-piri- dilalilamina
ES493497A0 (es) Un procedimiento para preparar 1,2-dihidro-2-oxo-5-(piridi- nil)nicotinonitrilo
AR223521A1 (es) Un procedimiento para preparar una 3-alcoxi-6-alquilideno-hidrazinopiridazina
MX6898E (es) Procedimiento para preparar una composicion herbicida a base de n-alquil-2-halogenoacetanilidas
ES494226A0 (es) Procedimiento para preparar un 1,2,4-triazol-3-tiol
ES494827A0 (es) Procedimiento para preparar composiciones hebicidas,a base de n-cianoalquil-haloacetamidas.
MX5916E (es) Procedimiento mejorado para preparar 7-cloro-2-metil-3-3a-dihidro-2h,9h-isoxazol(3,2-b)(1,3)benzoxazin-9-ona
ES488808A0 (es) Un procedimiento para preparar derivados de fenotiazina